Merck's earnings call reveals challenges in its key franchises, including GARDASIL and SINGULAIR. xmlns: Reported revenue and EPS met expectations, but a reduced 2009 revenue guidance and backdrop of economic uncertainty and healthcare reforms indicate potential headwinds. The upcoming SAP system implementation, aimed at transforming business operations, adds complexity. Despite cost-cutting efforts and a strong balance sheet, these challenges may pressure the stock in the short term.
[-1]